A pancreatic cancer model was constructed using Panc02 pancreatic tumor cells with the type I receptor tyrosine kinase-like orphan receptor (ROR1) (Panc02/ROR1), which showed that valeric acid therapy increased the anti-tumor effectiveness of CAR-T cells in a pancreatic cancer model [39]. Here, ROR1 is linked to familial pancreatic carcinoma.